DECEMBER - 20215TECH OUTLOOKLAST WORDImproving Drug Shortage ManagementCXO INSIGHTSRecent Trend and Development in Pharmaceutical IndustryRichard Hu, Associate Director, CMC, Curis [NASDAQ:CRIS]23Revamping Drug Discovery and Development through Technology InnovationDr. Michelle M. Chen, VP & Head of Corporate Development, WuXi Biologics [HKG:2269]24Speed, Safety and Scalability: An Integrative Approach to Drug DevelopmentLinda Cherry, Vice President, and Doug Niven, PhD, Executive Director, Syneos Health26De-Risking the Preclinical Phase of Immunotherapy Drug DevelopmentRalph Gareus, Director Business Development, The Jackson Laboratory28C O NT E NT S30Ashley L. Pappas, PharmD, MHA, Director of Pharmacy Medication Management and Optimization, Pharmacy Analytics and Outcomes Pharmacy Services, UNC Health, and Greg Norsten, PharmD, PGY2 Health-System Pharmacy Administration and Leadership Resident, UNC HealthPg 16 - 22TOP 10 DRUG DISCOVERYAND DEVELOPMENT SOLUTION PROVIDERS - 2021TECH OUTLOOKChallenges and Opportunities for AI in Drug DiscoveryBobby Prill, Director, Data Science and AI, Computational Biology and Data Sciences, and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.20CREATIVE BIOLABS
< Page 4 | Page 6 >